Steven Prestrelski - Chief Scientific Officer, Xeris Pharmaceuticals Inc

As of April 13, 2021


Steven Prestrelski Net Worth

  • Net worth is estimated to be at least $1.97M
  • Owns at least 496,824 units of Xeris Pharmaceuticals Inc stock
  • Sold an estimated value of $890.01K in the last 3 years at Xeris Pharmaceuticals Inc

Steven Prestrelski Trading

  • Largest purchase of shares was 15,720 units , worth over $18.71K on January 2, 2019
  • Largest sale of shares was 27,700 units , worth over $332.6K on October 16, 2019
  • In total has made about 15 transactions over 3 years
  • Usually trades in January, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Steven Prestrelski Mailing Address

  • Mailing address is C/o Xeris Pharmaceuticals 180 N. Lasalle Street, Suite 1800 Chicago IL 60601 IL

Xeris Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Paul Edick, 2020 $626,977 $1,178,450 $ $453,222 $5,700 $2,264,349
Paul Edick, 2019 $598,277 $1,735,000 $1,598,580 $370,181 $5,600 $4,307,638
John Shannon, 2020 $473,658 $414,050 $246,300 $300,000 $2,420 $1,436,428
John Shannon, 2019 $444,479 $ $639,432 $178,500 $5,171 $1,267,582
Beth Hecht, 2020 $392,852 $286,650 $369,450 $189,808 $5,634 $1,244,394
Beth Hecht, 2019 $364,417 $ $259,769 $145,782 $5,600 $775,568
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1346302/000134630221000036/a2021proxystatement.htm

Xeris Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 10,000 units sold on April 13, 2021 by Steven Prestrelski worth over $40.73K
  • In the last 3 years, insiders at Xeris Pharmaceuticals Inc sold an estimated value of $3.16M and bought an estimated value of $30.43M
  • The most active traders are Steven Prestrelski, Chief Scientific Officer,  Patrick John Shannon Jr, See Remarks,  and Beth Hecht, See Remarks
  • Insider trading is most common in February, with the busiest year in 2020

XERIS PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1